Fig 1.
Consort enrollment of patients enclosed in the study.
Fig 2.
Neuron-Specific Enolase (NSE) serum levels.
Clinical biochemistry data on NSE in Group 1: SC-2D, Group 2: SC-2, and Group 3: Control. Results are shown as mean ± SD. The analysis of variance test was performed to evaluate the differences between groups. ***P<0.01. P values remained significant after Bonferroni comparisons (P<0.01).
Table 1.
Clinical characteristics of enrolled patients.
Fig 3.
Inflammation biomarkers serum levels.
Clinical biochemistry data on interleukin-6 (IL-6), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and procalcitonin in Group 1: SC-2D, Group 2: SC-2, and Group 3: Control. Results are shown as mean ± SD. The analysis of variance test was performed to evaluate the differences between groups. ***P<0.01. P values remained significant after Bonferroni comparisons (P<0.01).
Fig 4.
Computed tomography (CT) of two patients infected with SARS-CoV-2 with (Group 1, SC-2D) (A) and without (Group 2, SC-2) (B) dyspnea.
In both images, interlobular septal thickening and patchy ground-glass opacities are evident.